Search Results (628)

Tunicate (marine invertebrates)-derived cellulose nanocrystals (T-CNC) possess unique structural and physicochemical properties compared to other wood-based CNCs. This study aimed to characterize and utilize T-CNC as a stabilizer in Pickering emulsion (PE), highlighting a sustainable alternative to conventional surfactant-based emulsifiers. Characterization of T-CNC revealed a rod-shaped morphology with dimensions of 1694 ± 925 nm in length and 13 ± 3 nm in width, resulting in an aspect ratio of 122 ± 45, and high crystallinity (87.6%). Its zeta potential ranged from −4.4 to −45.5 mV across pH 2–10 and contact angles <50° indicate strong water wettability. T-CNC at 0.2%, 0.3%, and 0.4% (w/w) at pH 3 and 5 was used to prepare 20 wt% oil-in-water PE using a high-shear homogenizer followed by ultrasonication. Ultrasonication significantly improved the emulsion stability compared to only high-shear homogenization, decreasing droplet size by 31.4–50.8% and 55.7–89.3% for pH 3 and pH 5, respectively. PEs developed at pH 3 demonstrated smaller droplet sizes, better stability with minimal coalescence after 7 days, and enhanced gel-like rheological behaviour compared to PEs at pH 5, which displayed flocculation and coalescence. The gel strength of the pH 3 PEs increased with T-CNC concentration, as evidenced by progressively denser droplet packing, consistent with stronger interfacial anchoring (higher detachment energy) and reduced coalescence. This study underscores T-CNC’s superior efficiency in stabilizing PEs at low concentrations, offering a green, high-performance solution for food, cosmetic, and pharmaceutical applications. Full article

Polymeric microfiltration membranes are among the most utilized pressure-driven membranes due to their excellent permeation flux, moderate removal efficiency, low operating pressure, low cost, as well as their potential for reusability and cleanability. Therefore, these membranes are used in different crucial sectors, including the water and wastewater, dairy, beverage, and pharmaceutical industries. However, well-known polymeric microfiltration membranes suffer from their poor hydrophilic properties, causing fouling phenomenon. A reduction in permeate flux, a shortened operational lifespan, and increased energy consumption are the primary negative consequences of membrane fouling. Over the years, a broad spectrum of studies has been performed to modify polymeric microfiltration membranes to improve their hydrophilic, transport, and antifouling characteristics. Despite extensive research, this issue remains a subject of ongoing discussion and scrutiny within the scientific community. This review article provides promising information about different physical and chemical modification methods—such as polymer blending, the incorporation of nanomaterials, surface coating, chemical crosslinking, in situ nanoparticle immobilization, and chemical surface functionalization—for polymeric microfiltration membranes. The physical and chemical modification methods are comparatively evaluated, highlighting their positive and negative aspects, supported by findings from recent investigations. Moreover, promising ideas and future-oriented techniques were proposed to obtain polymeric microfiltration membranes containing superior efficiency, extended service life, and mechanical strength. Full article

Modifying proteins through grafting with polyphenols has received much attention recently due to its immense application potential. This stems from the formation of protein-polyphenol complexes, altering the structural and functional properties of the constituent molecules. In food systems, the interaction between proteins and polyphenols, including covalent and non-covalent binding, represents a green, simple, and effective strategy to transform difficult-to-process protein sources into high-value functional ingredients. In addition, the complexes formed can increase stability, biological activity, and bioavailability of polyphenols, thereby expanding their applications. Gaining insight into protein-polyphenol complexes is essential for developing novel complexes, formulations, and other applications utilizing protein and natural polyphenols. Thus, this review outlines the binding affinities and interaction mechanisms, explains factors affecting complex formation, revisits structural modulation of protein, modern processing technologies, and systematically discusses the synergistic bioactivities of the resulting complexes. We also discuss strategies to address the applications of protein–polyphenol complexes for developing functional food products with prolonged shelf life. These applications can be expanded to other industrial areas, such as pharmaceuticals and material engineering, contributing towards better nutritional quality, beneficial healthy aspects, and sustainability. Full article

The Bactericidal action of β-lactam antibiotics is related to covalent modification of transpeptidases, enzymes that take part in the synthesis of bacterial cell wall. The β-lactam moiety mimics the transpeptidase substrate and irreversibly inhibits the enzyme. In penicillin and cephalosporin, the β-lactam ring is coupled with a five-membered thiazolidine ring or a six-membered dihydrothiazine ring, respectively. In the case of penicillins, such conjunction causes higher tension of this bicyclic moiety; therefore, the β-lactam ring can be hydrolyzed in certain conditions, inactivating the antibiotic. Serum albumin is known for its drug binding capabilities, which enable it to transport pharmaceuticals through the circulatory system. Penicillins and cephalosporins are no exception in this aspect, and they are also carried by serum albumin in the bloodstream. In this study, we structurally investigate the ability of three serum albumins—equine (ESA), caprine (CSA), and ovine (OSA)—to bind two penicillins, ampicillin (Amp) and oxacillin (Oxa), and two cephalosporins, cefaclor (Cef) and cephalosporin C (Csc). The crystal structures of these mammalian serum albumin complexes shed new light on the albumin binding properties of β-lactam antibiotics, showing one common binding site for Amp, Oxa, and Cef in Fatty Acid Site 6 (FA6), and a second cefaclor molecule bound in domain I of the equine serum albumin. It was surprising that these antibiotics are not bound in the main drug binding site. However, cephalosporin C is bound in OSA Drug Site 1 (DS1). Full article

The present work provides a detailed study of Convolvulus cantabrica L., a plant belonging to the family Convolvulaceae and the genus Convolvulus. The selection of this plant was based on the long-standing ethnobotanical relevance of its genus, which was attributed to the richness of its species in phenolic and flavonoids compounds. Moreover, this species as remained unexplored to date. Our investigation includes both chemical and biological aspects. To assess the chemical composition of the hydroalcoholic extract of the plant, High-Performance Liquid Chromatography (HPLC) analysis was performed. Rosmarinic Acid (161.9 ppm) and Chlorogenic Acid (153.8 ppm) had the highest concentrations. Gas Chromatography–Mass Spectrometry (GC-MS) analysis demonstrated the presence of Fatty Acids and Esters (70.81%), sesquiterpene and diterpenes (19.51%) and fatty alcohols (6.02%). In addition, the ethyl acetate extract exhibited the highest phenolic contents (606.42 µg/mL) and flavonoid contents (363.75 µg/mL). The tested extracts, especially the ethyl acetate and butanol extracts, exhibited strong antioxidant capacity in DPPH (IC₅₀: 13.60 ± 1.30 µg/mL for ethyl acetate extract and 17.69 ± 1.17 µg/mL for butanol extract), ABTS (IC₅₀: 7.26 ± 0.01 µg/mL for ethyl acetate extract and 6.90 ± 0.18 µg/mL for butanol extract) and FRP (IC₅₀: 14.89 ± 0.90 µg/mL for ethyl acetate extract and 23.14 ± 0.60 µg/mL for butanol extract) assays compared with extracts from other species of this genus. Moreover, the petroleum ether extract demonstrated anti-inflammatory activity (IC₅₀: 419.30 ± 4.48 µg/mL). Regarding antibacterial activity, the plant extracts, especially the ethyl acetate, hydroalcoholic and petroleum ether extracts, inhibited the growth of Bacillus cereus. Overall, our data indicate that Convolvulus cantabrica L., is rich in secondary metabolites, particularly polyphenols, and exhibits significant biological activities, especially antioxidant properties. These results validate the traditional use of C. cantabrica and position it as a promising source of natural antioxidants with potential pharmaceutical and nutraceutical applications. Full article

Disorders in the oral cavity caused by pathogenic fungi pose a significant clinical challenge, particularly in immunocompromised patients, as well as those undergoing oncological therapy or antibiotic treatment. A practical therapeutic approach involves the topical application of mucoadhesive drug dosage forms. However, only a limited number of such preparations are available on the pharmaceutical market. Mucoadhesive systems are especially advantageous, as they ensure prolonged retention and adequate concentrations of the active substances at the site of infection. Localized drug delivery enhances therapeutic efficacy compared to systemic administration, enabling lower drug doses, and consequently reducing the risk of side effects. Moreover, many fungal conditions require long-term treatment, which may be optimized by the use of mucoadhesive systems, improving patient compliance. Considering the issue of limited adhesion of conventional drug dosage forms and the moist environment in the oral cavity, providing optimal mucoadhesive properties is a key aspect. This article presents a comprehensive overview of the significance of treating oral candidiasis using mucoadhesive drug dosage forms, the mechanisms and advantages of mucoadhesion (including relevant polymers), and, most importantly, recent scientific reports on the development and quality assessment of mucoadhesive drug delivery systems for the management of oral fungal diseases. Full article

Microalgal production has garnered increasing interest from both researchers and industry due to the wide range of biomass applications in food, feed, cosmetics, and pharmaceuticals. The successful cultivation of microalgae requires not only adequate supply of nutrients but also large volumes of water. The development of green technologies aimed at sustainable microalgae biomass production is expanding, though it presents several technological challenges. Recycling spent culture media and nutrients has emerged as a promising strategy to reduce water consumption and cultivation costs while supporting environmentally friendly practices. In this review, we first highlight the role of macro- and micronutrients in microalgal growth, then examine physicochemical and physical treatments for optimizing medium reuse, discuss the economic aspects of microalgae production, and outline key technologies for sustainable cultivation. The review underscores the potential of medium recycling to significantly lower costs and environmental impact, paving the way for a more sustainable and economically viable microalgae industry. Full article

Recently, the environmental impact of halocarbons has become increasingly concerning, particularly due to the growing influence of non-regulated halocarbons on stratospheric ozone depletion and their adverse health effects in the troposphere. Previous model studies have highlighted the importance of halocarbon emissions from the YRD. However, only several reports have discussed the long-term pollution characteristics and health risks of halocarbons in the YRD based on observational data. The continuous observation of halocarbons was conducted in the central part of the YRD (Shanxi site) from 2018 to 2023. The result showed that rise in halocarbon levels was primarily driven by alkyl halides, including dichloromethane (1.194 ppb to 1.831 ppb), chloromethane (0.205 ppb to 1.121 ppb), 1,2-dichloroethane (0.399 ppb to 0.772 ppb), and chloroform (0.082 ppb to 0.300 ppb). The PMF and CBPF analysis revealed that pharmaceutical manufacturing (37.0% to 60.2%), chemical raw material manufacturing (8.0% to 19.9%), solvent use in machinery manufacturing (12.4% to 24.7%), solvent use in electronic industry, and background sources were the main sources of halocarbons at the Shanxi site. Among them, the contributions of chemical raw material manufacturing, as well as of solvent use in machinery manufacturing and electronic industry, are increasing. These aspects are all dominated by local emissions. Furthermore, the carcinogenic risks of chloroform and 1,2-dichloroethane, which rank first in this regard, are increasing. Also, attention should be paid to solvent use in the electronic industry and the background. The probabilities of these activities coming with health risks that exceed the acceptable levels are 94.8% and 94.9%. This study enriches the regional observation data in the YRD region, offering valuable insights into halocarbon pollution control measures for policy development. Full article

The widespread use of anticancer drugs (ACDs) in human therapies determines the occurrence of these potent cytotoxic chemicals into aquatic ecosystems. Nowadays, ACDs are ubiquitous contaminants in wastewater effluents and freshwater compartments, raising urgent questions about their environmental impact. Designed to disrupt cellular proliferation, these compounds are inherently bioactive and can exert toxic effects on non-target organisms even at trace concentrations. Conventional fate and toxicity tests provide important initial data but are limited in ecological realism, often focusing on single-specie and single-endpoint under controlled conditions and overlooking complex interactions, trophic dynamics, and long-term chronic exposures. Knowledge of all these aspects is needed for proper monitoring, assessment, and regulation of ACDs. Simulated ecosystem experiments, such as mesocosms, provide intermediate-scale, semi-controlled platforms for investigating real-world exposure scenarios, assessing ACD fate, and identifying both direct and indirect ecological effects. They offer distinct advantages for evaluating the chronic toxicity of persistent pollutants by enabling realistic long-term contamination simulations and supporting the simultaneous collection of comprehensive hazard and exposure endpoints. This perspective underscores the growing concern surrounding the contamination of ACDs, examines the limitations of traditional assessment approaches, and advocates for mesocosm-based studies as a critical bridge between laboratory research and ecosystem-level understanding. By integrating mesocosm experiments into environmental fate and risk evaluation, we can better predict the behavior and ecological consequences of anticancer pharmaceuticals, guiding strategies to mitigate their impact on aquatic life. Full article

Perfluorooctane sulfonate (PFOS) has been widely utilized in products such as cotton textiles, hydraulic oils, coatings, pharmaceuticals, cosmetics, etc. Now it is widely distributed in various environmental media, wildlife, and human bodies. Polystyrene (PS) as a kind of plastics, their products under the physical, chemical, and biological decomposition in the environment are widely distributed in the air, soil, oceans, surface water, and sediments. However, PS and PFOS often coexist in the environment, making the study of their combined exposure mechanisms more aligned with actual conditions. This research integrates network toxicology and molecular biology techniques to predict the toxicity and common differentially expressed gene enrichment pathways of PFOS and PS. This study investigates the toxic effects of combined exposure to PFOS and PS on the mouse growth and development, immune functions, and other aspects. Additionally, it delves into the expression differences in various genes in mice after stimulation by PFOS and PS, the pathological changes in multiple organs, and the toxic effects on organs such as the liver, kidneys, and intestines. The results reveal that combined exposure to PFOS and PS does not significantly damage the kidney but leads to morphological damage in the liver and intestinal tissues, reduced antioxidant capacity, and the occurrence of inflammation. Based on the network toxicology findings, it is hypothesized that during combined exposure to PFOS and PS, the exacerbation of inflammatory responses further mediates the reduction in antioxidant capacity and the intensification of oxidative stress, ultimately resulting in tissue damage. This study provides innovative theoretical and research directions for the detection and prevention of combined exposure to PFOS and PS, offering a new paradigm for toxicological research, with significant theoretical and practical implications. Full article

Polyethylene glycol (PEG) has been extensively utilized in drug formulations due to its multifunctional properties, i.e., hydrophilicity and biocompatibility. The roles played by PEG (as a drug delivery carrier and a solubilizer) improve the dissolution profile of several active pharmaceutical ingredients (APIs), leading to an improved absorption, distribution, metabolism, excretion, and toxicity (ADMET) profile. Moreover, PEG aids in upgrading the existing mechanical properties (as a binding agent, a plasticizer, etc.). Furthermore, PEG, due to its unique ability to provide “stealth” properties, is a valuable tool in pharmaceutical nanotechnology. Exploiting physicochemical variables, PEG acts as a coating/conjugation component of nanocarriers for ameliorating permeability and enhancing in vivo circulation without clearance by the body’s immune system. Additionally, PEG’s presence at the target site decreases external interactions and enhances the pharmacological attributes in terms of loading efficiency and controlled release. Nevertheless, cases of hypersensitivity or allergy, as well as anaphylactic shocks and allergic reactions, have been detected. The topic of this article is the exploitation of PEG’s physicochemical properties in the study of drug delivery, focusing on solid dosage forms and nanovesicles, along with the evaluation of its contribution to the fabrication of safe delivery and theragnostic systems. Full article

Frailty among older adults heightens their risk of negative health outcomes, and medication use plays a major role in this increased vulnerability. Various aspects of medication use elevate the risk of poor outcomes in individuals with frailty. The current scoping review was designed to explore medication use in older adults with frailty in primary care, focusing on the prevalence of potentially inappropriate medications (PIMs), polypharmacy, medication adherence, and their role in contributing to adverse drug events. This scoping review was conducted using the Arksey and O’Malley, supplemented by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Extension for Scoping Reviews (PRISMA-ScR) guidelines. A search of the literature was conducted from inception to November 2023 in Ovid EMBASE, PubMed (MEDLINE), Scopus, EBSCOhost CINAHL, and Ovid International Pharmaceutical Abstracts. Studies which met the eligibility criteria included older adults with frailty (≥65 years) living at home, defined frailty criteria, and assessment of medication use. Out of the 4726 studies screened, 223 were included, conducted across 39 countries. Frailty prevalence varied widely from 0.9% to 89.2%. Polypharmacy (5–9 medications) and hyper-polypharmacy (≥10 medications) were notably more common among individuals with frailty, with polypharmacy rates ranging from 1.3% to 96.4%. Twelve studies reported PIM prevalence among individuals with varying levels of frailty, ranging from 2.4% to 95.9%. This scoping review highlights the challenges and complexities involved in understanding the relationship between medication use and frailty in older adults. Full article

Monoclonal antibodies (mAbs) are an important medical innovation in modern medicine. They are an effective therapy for several subtypes of leukaemia but may have undesirable effects, which may be minimised through the provision of interdisciplinary care including a pharmacist. The goals of this narrative review were twofold: first, to summarise the literature on the side effects of mAbs and the challenges of their preparation, and to provide recommendations for the safe preparation of mAb drug formulations for clinicians. Second, to suggest clinical roles for pharmacists to improve patient safety and clinical outcomes for leukaemia patients receiving mAb therapy. The review covers data from 178 scientific and official sources of information on the types of targeted immunobiological drugs for the treatment of various types of leukaemia. The results are a detailed description of the possible side effects from mAb therapy and a list of suggested actions that can be taken to prevent them. Pharmaceutical aspects of the use of mAbs, such as pharmacoeconomics, compounding and stability, are also discussed. The discussion is organised according to the current classification of leukaemia. The drugs considered include blinatumomab, inotuzumab ozogamicin, gemtuzumab ozogamicin, rituximab, ofatumumab, obinutuzumab, and alemtuzumab. The review offers a comprehensive resource to equip pharmacists and other clinicians to optimise mAb therapy and promote the safe use of these novel therapies. Full article

Introduction: Diltiazem hydrochloride (DH) is a calcium channel blocker used in the treatment of hypertension, angina pectoris, and arrhythmias. Its short half-life and frequent dosing requirements limit patient adherence and cause plasma concentration fluctuations. Objective: This review critically examines recent pharmaceutical technologies and formulation strategies for modified-release dosage forms (MRDFs) of diltiazem hydrochloride, emphasizing their impact on pharmacokinetics, clinical performance, and regulatory aspects. Methodology: A structured literature review (2010–2025) was conducted using databases such as PubMed, ScienceDirect, MDPI, and ACS Publications. Studies were selected based on relevance to solid oral MRDFs of DH and their associated manufacturing techniques. Results: Techniques including direct compression, granulation, extrusion–spheronization, spray drying, solvent evaporation, and ionotropic gelation have enabled the development of hydrophilic matrices, coated pellets, microspheres, and osmotic systems. Functional polymers such as HPMC, Eudragit^®, and ethylcellulose play a central role in modulating release kinetics and improving bioavailability. Conclusions: This review not only synthesizes current formulation strategies but also explores reverse engineering of ideal release profiles and the integration of advanced modeling tools such as physiologically based pharmacokinetic (PBPK) modeling and in vitro–in vivo correlation (IVIVC). These approaches support the rational design of personalized, regulatory-compliant DH therapies. Full article

Lyophilization (freeze-drying) has become a cornerstone pharmaceutical technology for stabilizing biopharmaceuticals, overcoming the inherent instability of biologics, vaccines, and complex drug formulations in aqueous environments. The appropriate literature for this review was identified through a structured search of several databases (such as PubMed, Scopus) covering publications from late 1990s till date, with inclusion limited to peer-reviewed studies on lyophilization processes, formulation development, and process analytical technologies. This succinct review examines both fundamental principles and cutting-edge advancements in lyophilization technology, with particular emphasis on Quality by Design (QbD) frameworks for optimizing formulation development and manufacturing processes. The work systematically analyzes the critical three-stage lyophilization cycle—freezing, primary drying, and secondary drying—while detailing how key parameters (shelf temperature, chamber pressure, annealing) influence critical quality attributes (CQAs) including cake morphology, residual moisture content, and reconstitution behavior. Special attention is given to formulation strategies employing synthetic surfactants, cryoprotectants, and stabilizers for complex delivery systems such as liposomes, nanoparticles, and biologics. The review highlights transformative technological innovations, including artificial intelligence (AI)-driven cycle optimization, digital twin simulations, and automated visual inspection systems, which are revolutionizing process control and quality assurance. Practical case studies demonstrate successful applications across diverse therapeutic categories, from small molecules to monoclonal antibodies and vaccines, showcasing improved stability profiles and manufacturing efficiency. Finally, the discussion addresses current regulatory expectations (FDA/ICH) and compliance considerations, particularly regarding cGMP implementation and the evolving landscape of AI/ML (machine learning) validation in pharmaceutical manufacturing. By integrating QbD-driven process design with AI-enabled modeling, process analytical technology (PAT) implementation, and regulatory alignment, this review provides both a strategic roadmap and practical insights for advancing lyophilized drug product development to meet contemporary challenges in biopharmaceutical stabilization and global distribution. Despite several publications addressing individual aspects of lyophilization, there is currently no comprehensive synthesis that integrates formulation science, QbD principles, and emerging digital technologies such as AI/ML and digital twins within a unified framework for process optimization. Future work should integrate advanced technologies, AI/ML standardization, and global access initiatives within a QbD framework to enable next-generation lyophilized products with improved stability and patient focus. Full article